0.7384
price down icon1.42%   -0.0106
 
loading

Iterum Therapeutics Plc Stock (ITRM) Forecast

The Iterum Therapeutics Plc (ITRM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $60.60, representing a +8,107% increase from the current price of $0.7384. The highest analyst price target is $61.87, and the lowest is $59.34.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ITRM Price Target
Average 52.64 (+7,028% Upside)
loading

Is Iterum Therapeutics Plc (ITRM) A Buy Now?

Oscillators
Name Value Action
RSI(14) 28.57 Buy
STOCH(9,6) 6.3293 Buy
STOCHRSI(14) 0.9547 Buy
MACD(12,26) -0.0646 Sell
ADX(14) 14.12 Neutral
William %R -92.91 Buy
CCI(14) -80.30 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.8104
Sell
0.8131
Sell
MA20
0.9062
Sell
0.8709
Sell
MA50
0.9512
Sell
0.954
Sell
MA100
1.0654
Sell
1.0655
Sell
MA200
1.3307
Sell
1.1796
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, ITRM could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ITRM, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 28.57 indicates that ITRM is oversold. This indicates that ITRM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 6.3293 indicates that ITRM is oversold. This indicates that ITRM price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.9547 indicates that ITRM is oversold. This suggests that ITRM price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 14.12 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -80.3 indicates that ITRM is still oversold but not to an extreme extent.

Long-term ITRM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Iterum Therapeutics Plc financial reports and earnings history, Iterum Therapeutics Plc (ITRM) stock could reach $100.51 by 2030, $71.32 by 2040 and $229.08 by 2050. See the projected annual prices until 2050 of the Iterum Therapeutics Plc stock below:

  • Iterum Therapeutics Plc (ITRM) is expected to reach an average price of $20.26 in 2035, with a high prediction of $24.64 and a low estimate of $21.23. This indicates an $2,644% rise from the last recorded price of $0.7384.
  • Iterum Therapeutics Plc (ITRM) stock is projected to chart a bullish course in 2040, with an average price target of $68.05, representing an $9,117% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $71.32.
  • Our analysts predict Iterum Therapeutics Plc (ITRM) to jump 18,354% by 2045, soaring from $136.47 to an average price of $136.26, potentially reaching $139.87. While $136.47 is the low estimate, the potential upside is significant.
  • Iterum Therapeutics Plc (ITRM) stock is expected to climb by 2050, reaching an average of $223.56, a $30,176% jump from its current level. However, a wide range of estimates exists, with high and low targets of $229.08 and $225.36, respectively, highlighting the market's uncertainty.

Iterum Therapeutics Plc Stock (ITRM) Year by Year Forecast

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2025

Iterum Therapeutics Plc Stock (ITRM) is expected to reach an average price of $47.17 in 2025, with a high prediction of $66.69 and a low estimate of $27.65. This indicates an +6,288% rise from the last recorded price of $0.7384.
Month Average Low High Change from today's price
August, 2025 $62.27 $59.34 $61.87 +8,333%
September, 2025 $63.13 $63.63 $62.08 +8,450%
October, 2025 $67.92 $65.48 $65.86 +9,099%
November, 2025 $59.71 $66.26 $66.69 +7,986%
December, 2025 $66.62 $61.24 $65.78 +8,922%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2026

The predicted value for Iterum Therapeutics Plc (ITRM) in 2026 is set at an average of $46.48. Estimates vary from a peak of $65.59 to a trough of $27.36, indicating an +6,195% surge from the present price of $0.7384.
Month Average Low High Change from today's price
January, 2026 $60.90 $64.24 $65.59 +8,147%
February, 2026 $57.52 $58.05 $60.44 +7,690%
March, 2026 $51.41 $53.66 $54.96 +6,863%
April, 2026 $36.78 $38.58 $44.52 +4,881%
May, 2026 $41.39 $43.04 $40.84 +5,505%
June, 2026 $45.25 $44.10 $42.96 +6,028%
July, 2026 $47.57 $46.91 $46.82 +6,342%
August, 2026 $33.73 $37.92 $45.27 +4,468%
September, 2026 $40.55 $27.36 $37.85 +5,391%
October, 2026 $47.17 $43.36 $46.21 +6,289%
November, 2026 $47.37 $47.67 $47.79 +6,315%
December, 2026 $47.31 $47.17 $46.73 +6,307%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Iterum Therapeutics Plc (ITRM) is $40.41, with a high forecast of $46.18 and a low forecast of $34.65. This indicates an +5,373% increase from the last price of $0.7384.
Month Average Low High Change from today's price
January, 2027 $46.47 $46.48 $46.18 +6,193%
February, 2027 $45.48 $45.01 $44.46 +6,060%
March, 2027 $44.05 $44.48 $44.91 +5,866%
April, 2027 $43.94 $44.09 $43.48 +5,850%
May, 2027 $42.32 $43.26 $43.86 +5,631%
June, 2027 $41.15 $41.27 $41.57 +5,473%
July, 2027 $39.95 $39.89 $40.45 +5,311%
August, 2027 $39.68 $39.81 $39.41 +5,273%
September, 2027 $38.80 $39.16 $39.17 +5,155%
October, 2027 $37.69 $37.96 $38.21 +5,005%
November, 2027 $35.78 $36.36 $37.20 +4,746%
December, 2027 $33.74 $34.65 $34.59 +4,470%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2028

In 2028, Iterum Therapeutics Plc (ITRM) is projected to reach an average price of $26.30, with a high projection of $34.00 and a low estimate of $18.60. This indicates an +3,462% rise from the last price of $0.7384.
Month Average Low High Change from today's price
January, 2028 $33.82 $33.84 $34.00 +4,480%
February, 2028 $33.25 $33.28 $33.49 +4,403%
March, 2028 $31.45 $31.49 $32.47 +4,159%
April, 2028 $30.42 $30.54 $31.06 +4,019%
May, 2028 $29.19 $29.23 $30.04 +3,854%
June, 2028 $27.45 $27.53 $28.79 +3,617%
July, 2028 $25.96 $26.02 $27.05 +3,415%
August, 2028 $24.54 $24.54 $25.57 +3,224%
September, 2028 $23.15 $23.20 $23.77 +3,035%
October, 2028 $21.61 $21.68 $22.53 +2,826%
November, 2028 $19.78 $19.84 $21.18 +2,579%
December, 2028 $18.54 $18.60 $19.36 +2,410%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2029

The 2029 price forecast for Iterum Therapeutics Plc Stock (ITRM) is $45.29 on average, with a high prediction of $90.12 and a low estimate of $0.4629. This represents an +6,034% increase from the previous price of $0.7384.
Month Average Low High Change from today's price
January, 2029 $16.81 $16.85 $18.08 +2,177%
February, 2029 $15.59 $15.61 $16.45 +2,012%
March, 2029 $14.32 $14.35 $15.22 +1,839%
April, 2029 $12.95 $13.01 $13.94 +1,654%
May, 2029 $11.18 $11.26 $12.51 +1,415%
June, 2029 $8.4658 $8.7571 $9.8266 +1,047%
July, 2029 $7.2282 $7.8082 $8.0389 +878.90%
August, 2029 $5.9236 $6.0135 $6.6512 +702.22%
September, 2029 $4.8059 $4.8562 $5.4567 +550.85%
October, 2029 $2.7413 $2.8013 $4.3822 +271.25%
November, 2029 $1.5236 $1.5336 $2.3244 +106.34%
December, 2029 $101.97 $0.4629 $90.12 +13,710%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2030

Iterum Therapeutics Plc Stock (ITRM) is expected to reach an average price of $122.19 in 2030, with a high forecast of $148.17 and a low forecast of $96.21. This signifies an +16,448% surge from the last price of $0.7384.
Month Average Low High Change from today's price
January, 2030 $92.95 $101.28 $100.51 +12,488%
February, 2030 $101.30 $106.38 $99.63 +13,619%
March, 2030 $99.40 $100.75 $99.38 +13,362%
April, 2030 $101.56 $96.21 $97.82 +13,654%
May, 2030 $105.31 $99.16 $101.26 +14,161%
June, 2030 $136.88 $122.16 $131.48 +18,437%
July, 2030 $156.51 $147.94 $147.15 +21,096%
August, 2030 $142.96 $142.13 $148.17 +19,261%
September, 2030 $119.76 $121.41 $111.75 +16,119%
October, 2030 $137.05 $130.92 $136.73 +18,460%
November, 2030 $145.02 $141.06 $136.77 +19,539%
December, 2030 $132.04 $132.88 $141.30 +17,782%
$76.28
price down icon 1.69%
$37.39
price up icon 0.79%
$107.81
price up icon 2.66%
$27.43
price up icon 2.93%
$108.76
price down icon 1.19%
biotechnology ONC
$300.80
price up icon 0.15%
Cap:     |  Volume (24h):